Literature DB >> 1622413

The effect of food on the absorption of methotrexate sodium tablets in healthy volunteers.

G D Kozloski1, J M De Vito, J C Kisicki, J B Johnson.   

Abstract

OBJECTIVE: To examine the effect of food on the absorption and bioavailability of low-dose orally administered methotrexate sodium tablets.
METHODS: In this randomized, 2-way crossover study, a 7.5-mg dose of methotrexate (three 2.5-mg tablets) was administered to 12 healthy male volunteers after an overnight fast or within 10 minutes of consuming a high fat-content breakfast. Serum methotrexate concentrations over the next 24 hours were used to determine the area under the concentration-time curve (AUC), the maximum concentration, the time to maximum concentration (tmax), and the serum half-life for each phase.
RESULTS: Food delayed the tmax by approximately 30 minutes, but the extent of absorption, as measured by the AUC, for both phases was similar.
CONCLUSION: These results demonstrate that the bioavailability of low-dose orally administered methotrexate sodium tablets is not influenced by food.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1622413     DOI: 10.1002/art.1780350708

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

Review 1.  Food-drug interactions.

Authors:  Lars E Schmidt; Kim Dalhoff
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.

Authors:  B Bannwarth; F Péhourcq; T Schaeverbeke; J Dehais
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

Review 3.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

4.  The population pharmacokinetics of long-term methotrexate in rheumatoid arthritis.

Authors:  C Godfrey; K Sweeney; K Miller; R Hamilton; J Kremer
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

5.  Intraindividual variability of the bioavailability of low dose methotrexate after oral administration in rheumatoid arthritis.

Authors:  C Lebbe; C Beyeler; N J Gerber; J Reichen
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

Review 6.  Methotrexate in rheumatoid arthritis. An update.

Authors:  B Bannwarth; L Labat; Y Moride; T Schaeverbeke
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

Review 7.  Influence of Food on Paediatric Gastrointestinal Drug Absorption Following Oral Administration: A Review.

Authors:  Hannah K Batchelor
Journal:  Children (Basel)       Date:  2015-06-09

Review 8.  Molecular mechanism of action and pharmacokinetic properties of methotrexate.

Authors:  V Maksimovic; Z Pavlovic-Popovic; S Vukmirovic; J Cvejic; A Mooranian; H Al-Salami; M Mikov; S Golocorbin-Kon
Journal:  Mol Biol Rep       Date:  2020-05-15       Impact factor: 2.316

Review 9.  Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction.

Authors:  Kjeld Schmiegelow; Stine N Nielsen; Thomas L Frandsen; Jacob Nersting
Journal:  J Pediatr Hematol Oncol       Date:  2014-10       Impact factor: 1.289

10.  Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-03-21       Impact factor: 2.745

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.